Related Experiment Video

Updated: Feb 28, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
09:41

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

Published on: June 17, 2014

12.5K

Molecular regulation and pharmacological targeting of the β-catenin destruction complex

Eline C van Kappel1, Madelon M Maurice1

  • 1Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

British Journal of Pharmacology
|June 22, 2017
PubMed

Insights

The β-catenin destruction complex regulates Wnt signaling by degrading β-catenin. Recent findings reveal new regulatory mechanisms and therapeutic strategies for cancers caused by its inactivation.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Pathogenesis

Background:

  • The β-catenin destruction complex is crucial for Wnt signaling pathway regulation.
  • Its core components include axin, adenomatous polyposis coli, casein kinase 1, and glycogen synthase kinase 3.
  • Dysregulation of this complex is implicated in cancer development.

Purpose of the Study:

  • To review recent advances in understanding the regulation of the β-catenin destruction complex.
  • To discuss the mechanisms by which mutations in destruction complex components lead to Wnt signaling deregulation.
  • To explore potential therapeutic strategies targeting the destruction complex in cancer.

Main Methods:

  • Literature review of recent research on the β-catenin destruction complex.
  • Analysis of newly identified interaction interfaces and regulatory elements.
  • Examination of post-translational modifications and their impact on complex activity.

Main Results:

  • New insights into the dynamic regulation of the destruction complex.
  • Identification of distinct mechanisms by which mutations deregulate Wnt signaling.
  • Emerging therapeutic opportunities for restoring destruction complex function.

Conclusions:

  • Understanding the intricate regulation of the β-catenin destruction complex is key to deciphering Wnt pathway dysregulation in cancer.
  • Targeting the destruction complex offers promising therapeutic avenues for cancer treatment.

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

114.0K
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

11.2K

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.7K